The therapeutic effect of rituximab on C
β
Rie Hyo; Naoto Tomita; Kengo Takeuchi; Tomohiro Aoshima; Atsuko Fujita; Hideyuki
π
Article
π
2009
π
John Wiley and Sons
π
English
β 111 KB
## Abstract The prognosis of diffuse large Bβcell lymphoma (DLBCL) has improved markedly in recent years of rituximab era. The prognosis of __de novo__ CD5βpositive DLBCL is reported to be poor, but the effect of rituximab on this type of lymphoma remains unclear. To investigate the effect of ritux